Crossmark

ApoE4: an emerging therapeutic target for Alzheimer’s disease

Crossref DOI link: https://doi.org/10.1186/s12916-019-1299-4

Published Online: 2019-03-20

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Safieh, Mirna

Korczyn, Amos D.

Michaelson, Daniel M.
Funding

Funding for this research was provided by:

Israel Science Foundation

Joseph Sagol Foundation

Harold Eleanore Foonberg Foundation

Joseph K. and Inez Eichenbaum Foundation
License Information

Text and Data Mining valid from 2019-03-20
More Information

Article History

Received: 28 October 2018

Accepted: 5 March 2019

First Online: 20 March 2019

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: We confirm that we have read BMC’s guidance on competing interests and none of the authors have any competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.